中文 | English
Return
Total: 13 , 1/2
Show Home Prev Next End page: GO
Author:(Yungen XU)

1.Molecular mechanisms of combretastatin A-4 amino sugar derivative CPU-XT-008 on inhibiting proliferation of vascular endothelial cells

Shuying HE ; Rui XIONG ; Kun LIU ; Yungen XU

Journal of China Pharmaceutical University 2015;(5):594-599

2.Efficacy comparison of inverse less invasive stabilization system and Gamma nail for treatment of intertrochanteric fractures combined with lateral wall fractures

Lei HAN ; Yungen HU ; Weili FANG ; Bo JIN ; Shichao XU

Chinese Journal of Trauma 2017;33(1):57-62

4.Design, synthesis and Na+/H+ exchanger isoform-1 inhibitory activity of feruloylagmatine analogues.

Jiaming LI ; Yong HE ; Peng ZHOU ; Yungen XU ; Jiazhi PENG ; Rizheng SHENG

Acta Pharmaceutica Sinica 2011;46(8):936-41

6.Design, synthesis and biological study of BTK/JAK3 dual-target inhibitors

Lifang CEN ; Ming CHENG ; Weijie REN ; Liu YE ; Luhua WANG ; Weibo GUO ; Qiang ZHANG ; Yungen XU

Journal of China Pharmaceutical University 2024;55(1):73-86

7.Advances of near-infrared fluorescent probes for detection of Alzheimer′s disease

Yiran GE ; Jian YANG ; Yuyan LI ; Yungen XU

Journal of China Pharmaceutical University 2020;51(2):138-151

8.Advances of phosphoinositide-3 kinase inhibitors in combination with other drugs to overcome drug resistance

Chengshu JIA ; Junwei WANG ; Hui LI ; Qihua ZHU ; Yiran GE ; Yungen XU

Journal of China Pharmaceutical University 2017;48(5):523-528

9.Efficacy of titanium elastic intramedullary nail for treatment of clavicular shaft fractures in young and adolescent patients

Lei HAN ; Yungen HU ; Weili FANG ; Bo JIN ; Shichao XU

Chinese Journal of General Practitioners 2019;18(2):175-177

10.Research progress of ERK small molecule inhibitors

Tingting LIANG ; Wenjie WANG ; Guangchao HE ; Guangchao HE ; Yungen XU

Journal of China Pharmaceutical University 2020;51(3):260-269

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 13 , 1/2 Show Home Prev Next End page: GO